Physician profile
Todd R Larson
NPI 1609184365
$1,639.38
in general payments reported to CMS, 2019-2025
17 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $17.86 · 2021: $12.05 · 2022: $306 · 2023: $69.63 · 2024: $683 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897 · Education: $34.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.33 |
| Education | $34.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $612.89 | 2019-2024 | Lensx, Clareon |
| Carl Zeiss Meditec USA, INC. | $190.35 | 2024 | Eq Workplace |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $131.32 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $121.30 | 2022-2025 | Eylea Hd |
| Abbvie INC. | $101.56 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $72.98 | 2022-2025 | Envista Envy, Stellaris |
| Allergan, INC. | $71.11 | 2019-2021 | |
| The Cameron-Ehlen Group, INC. | $66.08 | 2019-2022 | |
| Apellis Pharmaceuticals, INC. | $57.43 | 2023-2025 | Syfovre |
| Oyster Point Pharma, INC. | $51.28 | 2024 | Tyrvaya, Ryzumvi |
| Astellas Pharma US INC | $32.94 | 2023 | |
| Kala Pharmaceuticals, INC. | $32.81 | 2019 | |
| Sun Pharmaceutical Industries INC. | $31.30 | 2019 | |
| Rxsight INC | $20.49 | 2022 | |
| Aerie Pharmaceuticals, INC. | $18.20 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $15.99 | 2019 | |
| Biotissue Holdings INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.